Soring ultrasonic dissection/aspiration devices

Soring Germany 8/9/96 ultrasonic dissection/aspiration devices

2. Failure to establish and implement specification control measures to assure that the design basis for the device is correctly translated into approved specifications, as required by 21 CFR 820.100(a)(1). For example, there is no documented software validation for the software which operates all devices manufactured by your firm.

Your response is not adequate. The investigator was assured that software used in all devices was fully tested and validated; however, no one took the time to document the procedures. The response included a test procedure entitled “Test Record for Software” to be used in the testing and validation of your software. No data was submitted showing that the validation has occurred. The investigator was told that the validation would be complete by 08/01/96. All validation data should be submitted to the FDA as soon as the studies are completed.

3. Failure to have specification changes approved and documented by a designated individual(s), including an approval date and the date the change became effective, as required by 21 CFR 820.100(a)(2). For example, there is no documented software validation for changes made in the software which operates all devices manufactured at your facility.

Since this was not listed on the FDA-483 you could not respond. However, you did respond to not having your software validated, FDA-483 item 1. The “Test Record for Software,” enclosed with your response, does not address re-validation of software if changes are made. All testing and validation of software should be documented, and the software should be re-validated following any changes.

O6. Failure to validate software programs by adequate and documented testing, when computers are used as part of a quality assurance system, and failure to routinely calibrate all quality assurance measurement equipment, as required by 21 CFR 820.61. For example:

a. There is no software validation for the two computer systems, [purged text], which conduct the final system testing for all units.

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.